Quantitative monitoring of CMV viral load in management of CMV reactivations in patients after allogeneic transplantation

被引：0
|
作者：
Hubacek, P [1 ]
Sedlacek, P [1 ]
Hyncicova, K [1 ]
Cinek, O [1 ]
Skapa, P [1 ]
Keslova, P [1 ]
Formankova, R [1 ]
Stary, J [1 ]
机构：
[1] Univ Hosp Motol, Prague, Czech Republic
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S176 / S176
页数：1
相关论文
共 50 条
  • [31] Donor and recipient CMV status and the risk of CMV activation after allogeneic stem cell transplantation.
    Juvonen, E
    Ruutu, T
    Eriksson, B
    Remes, K
    Volin, L
    Remberger, M
    Parkkali, T
    Hägglund, H
    Ringdén, O
    [J]. BLOOD, 2001, 98 (11) : 396A - 396A
  • [32] Quantitative analysis of CMV DNA in children after allogeneic haematopoietic stem cell transplantation.
    Mellgren, Karin
    Kullberg-Lindh, Carola
    Lindh, Magnus
    Friman, Vanda
    [J]. PEDIATRIC TRANSPLANTATION, 2007, 11 : 69 - 69
  • [33] Risk Factors for Progression of CMV Viremia to CMV Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Mack, Johnathan P.
    Tan, Xianming
    Vinh, Donald C.
    Popradi, Gizelle
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S296 - S297
  • [34] Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantation
    Peffault De Latour, Regis
    Chevallier, Patrice
    Blaise, Didier
    Alami, Sarah
    Levy-Bachelot, Laurie
    Allavoine, Thierry
    Tadmouri, Abir
    Blomkvist, Josefin
    Duhamel, Alain
    Srour, Micha
    Beauvais, David
    Yakoub-Agha, Ibrahim
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (12) : 3665 - 3673
  • [35] Immune Monitoring for CMV in Transplantation
    Yong, Michelle K.
    Lewin, Sharon R.
    Manuel, Oriol
    [J]. CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (04)
  • [36] Immune Monitoring for CMV in Transplantation
    Michelle K. Yong
    Sharon R. Lewin
    Oriol Manuel
    [J]. Current Infectious Disease Reports, 2018, 20
  • [37] Risk factors and prognostic scale for cytomegalovirus (CMV) infection in CMV-seropositive patients after allogeneic hematopoietic cell transplantation
    Cohen, L.
    Yeshurun, M.
    Shpilberg, O.
    Ram, R.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (04) : 510 - 517
  • [38] PREDICTIVE FACTORS OF SPONTANEOUS CMV VIRAL LOAD CLEARANCE IN KIDNEY TRANSPLANTATION
    Noble, J.
    Gatault, P.
    Longuet, H.
    Baron, C.
    Halimi, J. M.
    Gaudy-Graffin, C.
    Mounteanu, E.
    Alain, S.
    Buchler, M.
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 22 - 22
  • [39] QuantiFERON®-CMV for immune-monitoring after allogeneic stem cell transplantation:: preliminary data
    Morello, E.
    Cavattoni, I.
    Pagani, E.
    Monsurro, V.
    Coin, S.
    Cortelazzo, S.
    Larcher, C.
    Tridente, G.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S240 - S240
  • [40] Donor Anti-CMV Immunity is Associated with Fewer Reactivations after Allogeneic Hematopoietic Cell Transplant
    Chen, George L.
    Brix, Liselotte
    Wallace, Paul K.
    Zhang, Yali
    McCarthy, Philip L.
    Hahn, Theresa E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S391 - S392
12345